Eupraxia Pharmaceuticals Inc.

TSX:EPRX.TO

7.84 (CAD) • At close June 30, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CAD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q3
Omzet 000002.97900000000000000000
Kosten van de omzet 00.0760.0520.0580.051.4890.050.0490.0490.0550.050.0490.0390.0410.030.020.02000000
Brutowinst 000-0.058-0.051.489-0.05-0.049-0.049-0.055-0.05-0.049-0.039-0.041-0.03-0.02-0.02000000
Brutowinstmarge 000000.500000000000000000
Onderzoek- en ontwikkelingskosten 3.853.8824.053.9725.5986.8746.0964.6852.9696.4943.8524.9111.9461.8273.5563.6260.67-0.2150.2860.3970.451-0.3950.712
Algemene en administratieve kosten 3.2743.62.2232.5832.518-0.1992.5932.8431.2622.2520.9661.1831.4061.5731.4771.3324.5060.2350.30.2580.4920.6730.817
Verkoop- en marketingkosten 00000.860001.82800000000000000
Verkoop-, algemene en administratieve kosten 3.2743.62.2232.5833.378-0.1992.5932.8431.832.2520.9661.1831.4061.5731.4771.3324.5060.2350.30.2580.4920.6730.817
Overige kosten 000000000000000-0.325-1.936000000
Bedrijfskosten 7.1247.4826.2736.5558.9766.5278.8847.6494.7998.8024.8686.1433.3923.4415.0634.9785.1950.0410.6060.6760.9950.3311.578
Bedrijfsresultaat -7.124-7.482-6.273-6.555-9.027-6.349-8.624-7.445-4.847-8.575-4.675-6.028-3.356-3.41-5.043-5.288-7.131-0.062-0.606-0.676-0.995-0.331-1.567
Bedrijfsresultaat ratio 00000-2.13100000000000000000
Totaal overige inkomsten en kosten netto 0.360.4290.282-1.7490.73-4.4722.076-0.556-0.195-0.509-0.119-0.251-0.403-0.368-0.092-0.307-3.666-0.078-0.122-0.049-0.523-0.281-0.192
Inkomen voor belasting -6.764-7.531-5.991-8.304-8.296-4.315-6.548-8.001-5.042-9.083-4.795-6.28-3.76-3.777-5.135-5.595-8.862-0.14-1.062-0.99-2.153-0.713-1.759
Inkomen voor belasting ratio 00000-1.44800000000000000000
Belastingkosten 0.0030.0020-0.0050.007-0.2910.1990.39-0.0820.2030.2810.180.2660.2770.163-0.298-1.4860.4080.3920.4950.5460.5460.353
Nettowinst -6.763-7.509-5.943-6.007-8.15-4.096-6.314-7.827-4.96-8.823-4.656-6.09-3.691-3.718-4.974-5.437-8.86-0.138-1.06-0.983-2.146-0.735-1.745
Nettowinstmarge 00000-1.37500000000000000000
WPA (Winst Per Aandeel) -0.21-0.21-0.17-0.17-0.28-0.15-0.25-0.36-0.23-0.41-0.22-0.31-0.26-0.3-0.35-0.41-1.13-0.011-0.082-0.076-0.17-0.057-0.14
Verwaterde WPA -0.21-0.21-0.17-0.17-0.28-0.15-0.25-0.36-0.23-0.41-0.22-0.31-0.26-0.3-0.35-0.41-1.13-0.011-0.082-0.076-0.17-0.057-0.14
EBITDA -6.718-7.476-5.953-5.745-8.976-10.519-6.065-7.396-4.799-8.519-4.625-5.98-3.317-2.644-5.014-5.268-7.1110.313-0.585-0.34-1.091-0.135-1.517
EBITDA ratio 00000-3.53100000000000000000